期刊
CLINICAL BIOCHEMISTRY
卷 45, 期 9, 页码 641-645出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.clinbiochem.2012.02.023
关键词
oxLDL; Interleukin-1beta polymorphism; Cardiovascular risk factor
资金
- CNPq
- CAPES
- FAPEAM
- FAPERGS
Objectives: To investigate the association of the + 3953 IL-1B gene polymorphism in healthy subjects with serum oxidized LDL (oxLDL) levels. Design and methods: We selected 255 subjects who were non-smokers and who had no cardiovascular or other chronic degenerative diseases, and we measured the oxLDL and other glucose levels, lipid biomarkers and biological variables that are related to cardiovascular metabolism. The +3953 IL-1B gene polymorphism was determined using molecular genetics techniques (PCR-RFLP). Results: A significant association among the +3953 IL-1B genotypes and the oxLDL level was observed. The TT genotype presented lower oxLDL levels than the other genotypes. A multivariate analysis showed that this result was independent of the sex, age, obesity and hypertension status of the subjects. Conclusions: Our results suggest that the IL-1B gene polymorphism affects the modulation of serum oxLDL levels. (C) 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据